CD40 - CD40 molecule Gene

Also Known as TNFRSF5

生物種: Canis lupus familiaris (sub-species: familiaris)

遺伝子タイプ: protein coding
遺伝子ID: 403469

CD40 Products (1)

mRNA Protein Name
NM_001002982.1 NP_001002982.1 tumor necrosis factor receptor superfamily member 5 precursor
Protein Preferred Names Protein Names

tumor necrosis factor receptor superfamily member 5

  • B-cell surface antigen CD40

  • CD40 antigen (TNF receptor superfamily member 5)

  • CD40L receptor

  • tumor necrosis factor receptor superfamily, member 5

Recombinant CD40 Proteins

製品番号 製品名 アクセッション番号 純度
HY-P75411 CD40 Protein, Canine (HEK293, His) Q7YRL5 (E21-A194) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P75412 CD40 Protein, Canine (HEK293, Fc) Q7YRL5 (E21-A194) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P75413 CD40 Protein, Canine (HEK293) Q7YRL5 (E21-A194) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

阻害性抗体 (1)
製品番号 製品名 製品効果
純度 Rare Diseases
HY-P9950 Omalizumab Inhibitor 99.7% Unkown

Clinical Phase

Bioactive Molecules (3)
製品番号 製品名 製品効果
純度 Phase
HY-B1618 Corticosterone Agonist 99.77% Phase 3
HY-N6664 Gum arabic / Phase 3
HY-131968 BMS-986202 Inhibitor 99.29% Phase 1
阻害性抗体 (21)
製品番号 製品名 製品効果
純度 Phase
HY-P99625 Frexalimab Inhibitor 99.00% Phase 3
HY-P99845 Dazodalibep 99.0% Phase 3
HY-P99742 Mitazalimab Inhibitor 99.23% Phase 3
HY-P99046 Selicrelumab Agonist 99.29% Phase 2
HY-P99315 Ruplizumab Inhibitor 99.84% Phase 2
HY-P99670 Iscalimab Inhibitor 99.64% Phase 2
HY-P99049 Sotigalimab Agonist 98.90% Phase 2
HY-P990726 Abiprubart 99.00% Phase 2
HY-P99257 Bleselumab Inhibitor 98.97% Phase 2
HY-P99701 Letolizumab Inhibitor 98.32% Phase 2
HY-P99167 Lucatumumab Inhibitor ≥99.0% Phase 2
HY-P99015 Dacetuzumab Inhibitor 95.37% Phase 2
HY-P99821 Ravagalimab Inhibitor 99.31% Phase 2
HY-P99572 Tecaginlimab Inhibitor 99.00% Phase 2
HY-P991525 2141-V11 99.04% Phase 2
HY-P991510 CDX-1140 Agonist / Phase 2
HY-P991554 FFP-104 Modulator / Phase 2
HY-P991556 TQB2916 Agonist / Phase 2
HY-P991921 TNX-1500 Inhibitor / Phase 2
HY-P99325 Toralizumab Inhibitor 99.57% Phase 1
HY-P991666 BMS-986090 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (37)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-122663A BIO8898 Inhibitor 98.08% Unkown
HY-120323 DRI-C21045 Inhibitor 98.11% Unkown
HY-110247 TRAF-STOP inhibitor 6877002 Inhibitor 99.67% Unkown
HY-148980A Polyinosinic acid sodium 91.5% Unkown
HY-154821A DRI-C21041 DIEA Inhibitor 99.07% Unkown
HY-153345 Glucocorticoid receptor agonist-1 phosphate(2,6-difluoro) Ala-Ala-Br Agonist 99.67% Unkown
HY-49382 Fluocinolone acetonide 3-benzylaniline 99.93% Unkown
HY-154822 DRI-C25441 Inhibitor 99.53% Unkown
HY-118922 IW927 Inhibitor 99.23% Unkown
HY-152121 Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal Agonist 95.68% Unkown
HY-122663 (Rac)-BIO8898 Inhibitor 98.03% Unkown
HY-16668 Tyrphostin A1 Inhibitor 98.96% Unkown
HY-125025 SMI 6860766 Inhibitor / Unkown
HY-154821 DRI-C21041 Inhibitor / Unkown
HY-D1236 Fluorescent brightener 71 Inhibitor / Unkown
HY-P10399 KGYY15 Inhibitor 99.19% Unkown
HY-148980 Polyinosinic acid / Unkown
HY-143410 Anti-inflammatory agent 16 Inhibitor / Unkown
HY-148459 ATAC21 / Unkown
HY-171590 SIK2-IN-3 Inhibitor / Unkown
HY-179701 NIK-IN-3 Inhibitor / Unkown
HY-D1124 Mordant brown 1 / Unkown
HY-D3334 PE-CF594 / Unkown
HY-P10937 AQP4 (205-215) / Unkown
HY-P10937A AQP4 (205-215) TFA / Unkown
HY-P11915 GG13 Inhibitor / Unkown
HY-RS02246 CD40 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS02247 CD40LG Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-120471 AM-0687 Inhibitor / Unkown
HY-168384 M04 / Unkown
HY-174737 Human CD40LG mRNA / Unkown
HY-174738 Human CD40 mRNA / Unkown
HY-400878 Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal Agonist 99.86% Unkown
HY-RS16527 Cd40 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17669 Cd40lg Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22958 Cd40 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24130 Cd40lg Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
阻害性抗体 (21)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-P990680 Anti-Mouse CD40 Antibody (FGK4.5/FGK45) Inhibitor 98.35% Unkown
HY-P99842A Dapirolizumab Inhibitor 99.66% Unkown
HY-P990083 Tegoprubart Inhibitor 99.86% Unkown
HY-P990134 Anti-Mouse CD40L/CD154 Antibody (MR-1) Inhibitor 99.62% Unkown
HY-P990860 Anti-CD40 Antibody (G28.5) Inhibitor 95.00% Unkown
HY-P990133 Anti-Monkey/Human CD40L/CD154 Antibody (5C8) Inhibitor 95.00% Unkown
HY-P990111 BMS-986325 (anti-CD40) Inhibitor 99.84% Unkown
HY-P991513 BI-655064 Inhibitor 98.56% Unkown
HY-P99321 Teneliximab Inhibitor ≥99.0% Unkown
HY-P991126 Ciltistotug Ligand 95.376% Unkown
HY-P99663 Inezetamab Inhibitor 99.77% Unkown
HY-P990269 Anti-Mouse CD40L/CD154 (LALA-PG) Antibody (MR-1) Inhibitor 95.00% Unkown
HY-P991086 MGD010 Inhibitor 99.06% Unkown
HY-P990083A Tegoprubart (powder) Inhibitor / Unkown
HY-P990270 Anti-Mouse CD40L/CD154 (D265A) Antibody (MR-1) / Unkown
HY-P991460 Sym029 Agonist / Unkown
HY-P991555 XmAb5485 Inducer / Unkown
HY-P991557 ABI793 Inhibitor / Unkown
HY-P991918 KHK2840 Agonist / Unkown
HY-P991919 SBT-040 / Unkown
HY-P992408 MEDI-5083 / Unkown

Orthologs Information

生物種 Symbol 由来 ID
Homo sapiens CD40 NCBI NCBI:958